This paper introduced PHREND®, an AI-based algorithm that predicts the effectiveness of multiple sclerosis treatments for individual unique patients based on extensive longitudinal registry data. Tailored to patient-specific characteristics, PHREND® supports doctors and patients in making informed decisions to improve outcomes, reduce relapses, and enhance quality of life.